Status:
ACTIVE_NOT_RECRUITING
Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients with acute myeloid leukemia
Exclusion
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2030
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT03284593
Start Date
December 1 2014
End Date
December 1 2030
Last Update
July 30 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bordeaux
Bordeaux, France
2
University Hospital Toulouse
Toulouse, France, 31052